Company Overview and News

0
Can Sysco (SYY) Retain Solid Past Record Amid Cost Hurdles?

2018-07-13 zacks
Sysco Corporation (SYY - Free Report) has been in investors’ good books for quite some time now, courtesy of its splendid past record. The company has been gaining from a host of factors, especially its key growth strategies and strong U.S. Foodservice unit. This is well-reflected in its performance, as Sysco rallied as much as 41.3% in a year, against the industry’s decline of 2.5%.
LW SYY MED SAM BGS

17
They're Building the Straw of Tomorrow Now That Plastic's Passe - Bloomberg

2018-07-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MGM SYY AAL SBUX ALK

3
Can United Natural's Growth Strategies Wipe Off Cost Woes?

2018-07-09 zacks
United Natural Foods, Inc. (UNFI - Free Report) has been in good shape lately, with a flourishing organic food business and growing presence in the e-commerce space. Moreover, the company’s well-chalked strategic targets for 2018 are expected to add greater sheen to its expanding business. However, higher freight costs and labor expenses have been acting as roadblocks in its performance. That said, let’s closely inspect some of these factors impacting this renowned name in the natural and specialty food space.
SYY POOL ICE THS UNFI

1
Sysco: Wait For A Pullback

2018-06-22 seekingalpha
On June 21, Sysco Corporation (SYY) hit a new 52-week high, a consequence of the excellent performance of its domestic Foodservice Operations, its cost-cutting, and its acquisition of firms such as Costa Rican food distributor Mayca Distribuidores in November 2017 and Louisiana-based Doerle Food Services in February 2018. In light of these facts, the question of whether Sysco Corporation is worth investing in now must inevitably be raised.
SYY

1
Sysco (SYY) Touches 52-Week High: More Room for Growth?

2018-06-20 zacks
Sysco’s earnings surpassed the consensus mark, for the fourth straight quarter, in the third quarter of fiscal 2018. The company witnessed year-over-year growth in both the top and bottom lines. The primary reason behind strong results is its U.S. Foodservice Operations segment, wherein sales advanced 5.1% to $9,704.5 million on 2.6% growth in local case volume within U.S. Broadline operations, with total case volumes up 2.
SYY

528
Stocks To Watch: Don't Sleep On Vienna

2018-06-16 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
NPSNY SYY RUTH LX MS DECK SRRK EQIX JACK MDT TACOW KNSA VZ ZOES FB CLPS QNST MCRI KR SMTC CCL RYDAF EVOP INTC DRRX ICLK MUSA ITUB BB UNFI RHT PTIE HLF JPM MU FNKO HBNC SBUX LOCO PLAY XOM TWX MS.PRE MS.PRF MS.PRG RDSB TOT RDSA MS.PRA SHAK HMNY SAFM BKS AAN OSTK GSKY INCY CTLR CCL BP MS.PRI GOOGL MS.PRK FLL RYDBF MKSI FITB CLR BB PPC BC NDLS DOGZ FND DRI SGBXQ FINL WGO COP XHR DAL ORCL DIS JASO F RDS.B RDS.A TACO DISH TMSR SPTN FDX VLO GOLF CHUY SNY CHEF W ITRM SGBX CVX SNE

7
Investor LGIM seeks removal of eight company chairs over climate change inaction

2018-06-10 reuters
LONDON, June 11 (Reuters) - Britain’s biggest asset manager wants to remove the chairmen of the board at eight companies worldwide, which it says have failed to confront the threats posed by climate change.
CICHY SYY LBLCF OXY CICHF CCB 0939

1
Sysco (SYY) Up 3.6% Since Earnings Report: Can It Continue?

2018-06-06 zacks
It has been about a month since the last earnings report for Sysco Corporation (SYY - Free Report) . Shares have added about 3.6% in that time frame.
SYY

1
Sysco to Webcast Presentation From the Jefferies 2018 Global Consumer Conference

2018-06-06 globenewswire
HOUSTON, June 06, 2018 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that the Company will webcast its presentation from the Jefferies 2018 Global Consumer Conference in Nantucket, Massachusetts, on Wednesday, June 20, at 9:30 a.m. ET.
SYY

5
Sysco Announces Multi-Site Solar Garden Project in Texas

2018-06-06 globenewswire
HOUSTON, June 06, 2018 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY), the leading global foodservice distribution company, announced today that the Company has signed a ten-year renewable energy agreement with a subsidiary of NRG Energy, Inc. As part of the agreement, three solar garden sites are being constructed in the Houston and Dallas areas, which will support approximately 10 percent of Sysco’s U.
NRGEO SYY NRG

936
3
SYY / SYSCO Corp. 8-K/A (Current Report)

2018-05-27 sec.gov
8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
SYY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

49m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to SYY / SYSCO Corp. on message board site Silicon Investor.

Sysco Corporation (NYSE:SYY)
CUSIP: 871829107